Fergus Fleming - 01 Jul 2023 Form 3 Insider Report for Renalytix plc (RNLX)

Role
Chief Technical Officer, Director
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
RNLX
Transactions as of
01 Jul 2023
Transactions value $
$0
Form type
3
Filing time
03 Jul 2023, 16:20:15 UTC
Next filing
07 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RNLX Ordinary Shares 569,481 01 Jul 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RNLX Employee Stock Option (right to buy) 01 Jul 2023 Ordinary Shares 538,161 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each representing two Ordinary Shares.
F2 Fully vested and exercisable.
F3 The exercise price is 1.21 pounds sterling. The U.S. dollar equivalent of the exercise price is $1.53 using the Bank of England rate as of June 29, 2023 (1.00 pound sterling = $1.262).

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney